CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 5,392,546	$ 6,083,167
General and administrative	2,258,003	2,760,208
Total operating expenses	7,650,549	8,843,375
Operating loss	(7,650,549)	(8,843,375)
Other expense	(50,171)	0
Gain on derivative instruments	0	364,596
Other non-operating gains	0	(30,793)
Interest expense, net	(152,789)	(273,034)
Net loss	(7,853,509)	(8,782,606)
Modification of warrants	(171,552)	0
Net loss available to common shareholders	$ (8,025,061)	$ (8,782,606)
Net loss per common share - basic	$ (0.18)	$ (0.20)
Weighted average common shares outstanding - basic	43,440,387	43,077,961
Net loss per common share - diluted	$ (0.18)	$ (0.20)
Weighted average common shares outstanding - diluted	44,440,387	43,083,420